Synthesis and evaluation of 7-substituted 3-propargylamine coumarin derivatives as multifunctional monoamine oxidase and cholinesterase inhibitors for Alzheimer’s Disease treatme
| dc.contributor.advisor | Joubert, Jacques | |
| dc.contributor.advisor | Malan, Sarel | |
| dc.contributor.author | Mzezewa, Sheunopa C. | |
| dc.date.accessioned | 2020-11-02T09:15:07Z | |
| dc.date.accessioned | 2024-10-29T13:17:59Z | |
| dc.date.available | 2020-11-02T09:15:07Z | |
| dc.date.available | 2024-10-29T13:17:59Z | |
| dc.date.issued | 2020 | |
| dc.description | >Magister Scientiae - MSc | en_US |
| dc.description.abstract | Alzheimer’s Disease (AD) is a neurodegenerative disease which results from the irreversible loss of neurons in the brain. The disease is characterized by progressive cognitive impairment with recurrent short-term memory loss. AD is the leading cause of dementia and 4th leading cause of death in the elderly. Success in the treatment of AD has been limited, with drugs only treating it at a symptomatic level due to its pathology being complex and poorly understood. However, it is known that the cholinesterase and MAO-B enzymes play an important role in the disease through their association with production of amyloid plaques and oxidative stress respectively, two mechanisms associated with cell death and the symptoms seen in AD. | en_US |
| dc.identifier.uri | https://hdl.handle.net/10566/16350 | |
| dc.language.iso | en | en_US |
| dc.publisher | University of Western Cape | en_US |
| dc.rights.holder | University of Western Cape | en_US |
| dc.subject | Alzheimer’s disease | en_US |
| dc.subject | Neurodegeneration | en_US |
| dc.subject | Acetylcholinesterase | en_US |
| dc.subject | Monoamine oxidase | en_US |
| dc.subject | Multi-targeted directed ligands | en_US |
| dc.title | Synthesis and evaluation of 7-substituted 3-propargylamine coumarin derivatives as multifunctional monoamine oxidase and cholinesterase inhibitors for Alzheimer’s Disease treatme | en_US |